BLT
Click for more information
0.00% 2.6¢ benitec biopharma limited

optimism about gene therapy, page-2

  1. MutantSlab
    602 Posts.
    lightbulb Created with Sketch. 46
    clock Created with Sketch.
    30/12/12
    06:22
    Post #: 11235390
    Wall Street journal lists gene therapy as one of "six medical innovations that are poised to transform the way we fight disease". Gives Glybera a bump in the article. Also has DNA sequencing in the six...
    Nothing BLT holders didn't already know here.

    The Future of Medicine Is Now
    http://online.wsj.com/article/SB10001424127887323530404578205692226506324.html?mod=WSJ_hpp_LEFTTopStories
    BLT Price at posting: 35.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 12  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.